Prevalence, risk factors for and trends in faecal colonisation by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) in the community in Spain: A cross-sectional study and meta-analysis

被引:0
作者
Muniz, Gerard Munte [1 ,2 ]
Montesinos, Inmaculada Lopez [1 ,2 ]
Leon, Eduardo Padilla [4 ]
Marinero, Aida Esperanza Ramirez [4 ]
Montero, Milagro [1 ,2 ,3 ,6 ]
Sorli, Luisa [1 ,2 ,3 ,6 ]
Jorda, Xavier Duran [5 ]
Horcajada, Juan P. [1 ,2 ,3 ,6 ]
机构
[1] Hosp Mar, Barcelona, Spain
[2] Hosp Mar Res Inst IMIM, Barcelona, Spain
[3] Univ Pompeu Fabra UPF, Dept Med & Life Sci MELIS, Barcelona, Spain
[4] Lab Referencia Catalunya LRC, Barcelona, Spain
[5] Hosp Mar Res Inst IMIM, Stat Dept, Barcelona, Spain
[6] Inst Salud Carlos III, Ctr Biomed Res Infect Dis Network CIBERINFEC, Madrid, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2025年 / 43卷 / 06期
关键词
Extended-spectrum beta-lactamase (ESBL); Prevalence; Risk factors; Community; Healthy population; Meta-analysis; ESCHERICHIA-COLI; HEALTHY HUMANS; CARRIAGE; SAMPLES;
D O I
10.1016/j.eimc.2024.10.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To determine the prevalence of and risk factors for extended-spectrum beta-lactamaseproducing Enterobacterales (ESBL-PE) faecal carriage among healthy volunteers from Barcelona, and to estimate the pooled prevalence in the community in Spain. Methods: University students were asked to complete a questionnaire and provide a rectal swab, which was tested for ESBL-producing, ciprofloxacin-and trimethoprim-sulfamethoxazole-resistant Enterobacterales. Risk factors for carriage of antimicrobial resistance were identified by multivariate logistic regression. To place these results in the appropriate context, a systematic literature search was conducted to retrieve articles containing data on the prevalence of ESBL-PE faecal carriage in the community in Spain. To obtain the pooled prevalence, a random-effects meta-analysis was performed. Results: One hundred and thirty-five of 214 participants were included in the analysis. Faecal carriage of Escherichia coli/Klebsiella pneumoniae (E/K) resistant to at least one of the antibiotics tested was found in 32 participants (23.7%). Fourteen subjects carried ESBL-E/K (10.4%), with the CTX-M type being the most prevalent (85.7%). Risk factors for ESBL carriage were travel to a high-risk region in the past 3 years (OR 5.66; 95% CI 1.07-29.9) and living in a crowded city district (OR 6.91; 95% CI 1.22-39.08). Thirteen articles covering 21,760 individuals from Spain were included in the meta-analysis, giving a pooled prevalence rate for ESBL-PE carriage in the community of 5.8% (95% CI 4.1-7.8%), and a steady increase per year. Conclusions: The faecal colonisation prevalence by ESBL-PE among healthy individuals in Spain is high. It is associated with international travel and living in crowded city districts. (c) 2024 Sociedad Espanola de Enfermedades Infecciosas y Microbiolog & imath;a Cl & imath;nica. Published by Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 30 条
[1]  
[Anonymous], 2019, Breakpoint tables for interpretation of Disk diffusion and zone diameters
[2]  
Baquero F, 2006, Rev Esp Quimioter, V19, P51
[3]   Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review [J].
Ben, Yujie ;
Fu, Caixia ;
Hu, Min ;
Liu, Lei ;
Wong, Ming Hung ;
Zheng, Chunmiao .
ENVIRONMENTAL RESEARCH, 2019, 169 :483-493
[4]   The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community [J].
Bezabih, Yihienew M. ;
Sabiiti, Wilber ;
Alamneh, Endalkachew ;
Bezabih, Alamneh ;
Peterson, Gregory M. ;
Bezabhe, Woldesellassie M. ;
Roujeinikova, Anna .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (01) :22-29
[5]   β-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals [J].
Briñas, L ;
Zarazaga, M ;
Sáenz, Y ;
Ruiz-Larrea, F ;
Torres, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) :3156-3163
[6]   Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periods [J].
Castillo Garcia, F. J. ;
Garcia, C. Seral ;
Pardos De la Gandara, M. ;
Millan Lou, M. I. ;
Ferre, C. Pitart .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (01) :77-78
[7]   Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study [J].
Day, Michaela J. ;
Hopkins, Katie L. ;
Wareham, David W. ;
Toleman, Mark A. ;
Elviss, Nicola ;
Randall, Luke ;
Teale, Christopher ;
Cleary, Paul ;
Wiuff, Camilla ;
Doumith, Michel ;
Ellington, Matthew J. ;
Woodford, Neil ;
Livermore, David M. .
LANCET INFECTIOUS DISEASES, 2019, 19 (12) :1325-1335
[8]   Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) [J].
de Cueto, Marina ;
Aliaga, Luis ;
Alos, Juan-Ignacio ;
Canut, Andres ;
Los-Arcos, Ibai ;
Antonio Martinez, Jose ;
Mensa, Jose ;
Pintado, Vicente ;
Rodriguez-Pardo, Dolors ;
Ramon Yuste, Jose ;
Pigrau, Caries .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2017, 35 (05) :314-320
[9]   Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital [J].
Diaz-Agero Perez, Cristina ;
Lopez-Fresnena, Nieves ;
Rincon Carlavilla, Angela L. ;
Hernandez Garcia, Marta ;
Ruiz-Garbajosa, Patricia ;
Maria Aranaz-Andres, Jesus ;
Maechler, Friederike ;
Gastmeier, Petra ;
Bonten, Marc J. M. ;
Canton, Rafael .
BMJ OPEN, 2019, 9 (03)
[10]   The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world [J].
Doi, Yohei ;
Iovleva, Alina ;
Bonomo, Robert A. .
JOURNAL OF TRAVEL MEDICINE, 2017, 24 :S44-S51